Search details
1.
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
J Allergy Clin Immunol
; 152(2): 528-537, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36587851
2.
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.
J Allergy Clin Immunol
; 139(4): 1302-1310.e4, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-27658761
3.
Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.
Lancet Haematol
; 11(2): e114-e126, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38302222
4.
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
Contemp Clin Trials Commun
; 30: 101008, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36262801
5.
Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.
Contemp Clin Trials Commun
; 19: 100575, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32551397
6.
Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort Study.
Front Immunol
; 11: 589148, 2020.
Article
in English
| MEDLINE | ID: mdl-33193417
7.
Divergent members of a soybean (Glycine max L.) 4-coumarate:coenzyme A ligase gene family.
Eur J Biochem
; 269(4): 1304-15, 2002 Feb.
Article
in English
| MEDLINE | ID: mdl-11856365
Results
1 -
7
de 7
1
Next >
>>